文献速递艾滋病与性传播感染

晚期或病程不明梅毒:苄星青霉素1剂与3剂及多西环素疗效相当

Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016-2021.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该回顾性队列研究利用美国6个辖区2016–2021年晚期或病程不明梅毒监测数据,比较1剂与3剂苄星青霉素G及多西环素的疗效。在18 027例中,3剂BPG、1剂BPG和多西环素组24个月内非梅毒螺旋体血清滴度4倍下降比例分别为75%、80%和74%,各方案疗效相似。

要点

  • 1剂与3剂苄星青霉素G治疗晚期或病程不明梅毒的血清学疗效无差异。
  • 3剂苄星青霉素G与多西环素的疗效亦相当。
  • 按基线滴度、妊娠状态和HIV感染分层后结果仍一致。

核心结论

  • 未观察到1剂与3剂苄星青霉素G或多西环素治疗晚期或病程不明梅毒的疗效差异。

研究设计与样本

  • 回顾性队列研究,使用美国6个辖区2016–2021年晚期或病程不明梅毒监测数据,纳入18 027例。

主要发现

  • 3剂BPG组11 342例(63%),1剂BPG组1928例(11%),多西环素至少28天组3017例(17%)。
  • 24个月内非梅毒螺旋体血清滴度4倍下降比例:3剂BPG组75%,1剂BPG组80%,多西环素组74%。
  • 按基线滴度、妊娠状态和HIV感染分层后,各治疗组疗效仍相似。

关键数值与推荐

  • 疗效定义为治疗后24个月内非梅毒螺旋体血清滴度4倍下降。
  • BPG和四环素类治疗按记录剂量数和时间分类;多西环素组为至少28天。

临床怎么用

  • 本研究结果提示1剂BPG可能足以治疗晚期或病程不明梅毒,但需更多研究确认后再调整实践推荐。

局限性

  • 需更多观察性和临床研究,以更完整的治疗和血清学反应信息确认这些发现并指导实践推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little evidence supports the need for 3 weekly benzathine penicillin G (BPG) injections to treat late or unknown duration syphilis, and completion of the regimen may be difficult. We compared treatment effectiveness of 1 versus 3 doses of BPG and doxycycline. METHODS: We conducted a retrospective cohort study using surveillance data for cases diagnosed with late or unknown duration syphilis between 2016 and 2021 from 6 jurisdictions. We categorized BPG and doxycycline treatment based on the recorded number and timing of doses received. We defined treatment effectiveness as a 4-fold decrease in nontreponemal serum titer by 24 months posttreatment and compared treatment effectiveness using log binomial regression. RESULTS: Among 18 027 cases eligible for inclusion, over half had 3 doses of BPG recorded (11 342, 63%); relatively few had only 1 dose recorded (1928, 11%) or received at least 28 days of doxycycline (3017, 17%). Fourfold titer decreases were observed for 75% and 80% of cases given 3 doses and 1 dose of BPG, respectively, and for the 74% given doxycycline. Treatment effectiveness was similar across all treatment dose/interval categories and remained comparable when stratified by baseline titer, pregnancy status, and human immunodeficiency virus (HIV) infection. CONCLUSIONS: We did not observe a difference in treatment effectiveness between 1 and 3 doses of BPG, or between 3 doses of BPG and doxycycline, for late or unknown duration syphilis. Additional observational and clinical studies with more complete treatment and serologic response information are needed to confirm these findings and inform practice recommendations.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Pugsley RA, Davis NL, Cope AB, et al. Is 3 Really What We Need? Relative Effectiveness of Benzathine Penicillin G and Doxycycline Treatment Regimens for Late or Unknown Duration Syphilis in 6 US Jurisdictions, 2016-2021. Clin Infect Dis. 2026. PMID: 41725190. doi:10.1093/cid/ciag099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。